IBT
International Biotechnology Trust Portfolio holdings
AUM
$297M
This Quarter Return
+4.48%
1 Year Return
+17.25%
3 Year Return
+11.14%
5 Year Return
+79.35%
10 Year Return
–
AUM
$329M
AUM Growth
-$29.9M
(-8.3%)
Cap. Flow
-$30.4M
Cap. Flow
% of AUM
-9.26%
Top 10 Holdings %
Top 10 Hldgs %
51.54%
Holding
77
New
13
Increased
17
Reduced
12
Closed
16
Top Buys
| 1 |
Regeneron Pharmaceuticals
REGN
|
$11.4M |
| 2 |
Apellis Pharmaceuticals
APLS
|
$8.92M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$6.89M |
| 4 |
Gilead Sciences
GILD
|
$6.7M |
| 5 |
Alnylam Pharmaceuticals
ALNY
|
$6.65M |
Top Sells
| 1 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$40.5M |
| 2 |
Alkermes
ALKS
|
$16.7M |
| 3 |
Exelixis
EXEL
|
$10.5M |
| 4 |
Ultragenyx Pharmaceutical
RARE
|
$8.48M |
| 5 |
Sanofi
SNY
|
$7.81M |
Sector Composition
| 1 | Healthcare | 99.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
HUTCHMED
HCM
$2.62B
| $816K | 0.25% |
68,000
| – | – |
|
52
Beam Therapeutics
BEAM
$1.9B
| $750K | 0.23% |
23,500
| – | – |
|
53
PTC Therapeutics
PTCT
$4.41B
| $692K | 0.21% |
17,000
-76,000
| -82% | -$3.09M |
|
54
Agios Pharmaceuticals
AGIO
$2.36B
| $680K | 0.21% |
+24,000
| New | +$680K |
|
55
Protagonist Therapeutics
PTGX
$3.62B
| $549K | 0.17% |
+19,900
| New | +$549K |
|
56
Amylyx Pharmaceuticals
AMLX
$877M
| $539K | 0.16% |
+25,000
| New | +$539K |
|
57
Ventyx Biosciences
VTYX
$184M
| $491K | 0.15% |
15,000
| – | – |
|
58
Iovance Biotherapeutics
IOVA
$800M
| $457K | 0.14% |
65,000
+9,000
| +16% | +$63.3K |
|
59
Arvinas
ARVN
$580M
| $421K | 0.13% |
17,000
| – | – |
|
60
uniQure
QURE
$954M
| $178K | 0.05% |
15,500
-463,000
| -97% | -$5.31M |
|
61
Relmada Therapeutics
RLMD
$48.8M
| $24.7K | 0.01% |
10,000
| – | – |
|
62
Adicet Bio
ACET
$60.8M
| – | – |
-154,708
| Closed | -$890K |
|
|
63
Alkermes
ALKS
$4.95B
| – | – |
-593,000
| Closed | -$16.7M |
|
64
Ascendis Pharma
ASND
$12.1B
| – | – |
-29,400
| Closed | -$3.15M |
|
65
AstraZeneca
AZN
$255B
| – | – |
-65,000
| Closed | -$4.51M |
|
66
BioCryst Pharmaceuticals
BCRX
$1.74B
| – | – |
-57,000
| Closed | -$475K |
|
67
Caribou Biosciences
CRBU
$176M
| – | – |
-457,892
| Closed | -$2.43M |
|
68
CRISPR Therapeutics
CRSP
$4.82B
| – | – |
-34,200
| Closed | -$1.55M |
|
|
69
Exelixis
EXEL
$9.95B
| – | – |
-543,000
| Closed | -$10.5M |
|
70
Genmab
GMAB
$16.7B
| – | – |
-88,000
| Closed | -$3.32M |
|
71
IDEAYA Biosciences
IDYA
$2.26B
| – | – |
-19,000
| Closed | -$261K |
|
72
Ironwood Pharmaceuticals
IRWD
$201M
| – | – |
-60,000
| Closed | -$631K |
|
73
Novavax
NVAX
$1.2B
| – | – |
-132,500
| Closed | -$925K |
|
|
74
Sanofi
SNY
$122B
| – | – |
-143,500
| Closed | -$7.81M |
|
|
SGEN
75
DELISTED
Seagen Inc. Common Stock
SGEN
| – | – |
-200,200
| Closed | -$40.5M |
|